Class III
Ongoing
Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-do…
Why: Subpotent product:out of specification assay results observed during long term stability testing.
- Company
- SOMERSET THERAPEUTICS LLC
Somerset, NJ, United States - Reported
- Dec 24, 2025
- Recall started
- Nov 26, 2025
- Where sold
- Nationwide in the USA
- Amount
- 52,340 5mL vials
- Full product description
- Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.
- Lots / codes affected
- Lot#: A240438, Exp Date 1/31/26, A250125, Exp Date 8/31/26
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.